MTOR and Alzheimer disease: Chronic attenuation of mTOR pathway by rapamycin treatment could not only restore CBF and cerebrovascular density but also decrease CAA and micro‐hemorrhages, amyloid burden, and finally can block the progression of cognitive deficits in AD mouse brains through nitric oxide synthase (NOS) activation.131